RecruitingNot Applicable

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

China200 participantsStarted 2023-10-15

Plain-language summary

To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Samples diagnosed as biliary atresia in Children's Hospital of Fudan University * Samples with one-year follow-up records after surgery * Samples with a record of serum total bilirubin levels three months after surgery * Samples with preoperative serum left（volume \> 500ul) Exclusion Criteria: * None

What they're measuring

Serum total bilirubin level (umol/l)

Timeframe: Three months after surgery

Native liver survival (%)

Timeframe: One year after surgery

Trial details

NCT IDNCT05848310

SponsorChildren's Hospital of Fudan University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Shan Zheng

+86 021 64932791 szheng@shmu.edu.cn

View on ClinicalTrials.gov More Biliary Atresia trials